accountstill has the financial wherewithal to work through a downturn. In the meantime, investors are left waiting for King Pharmaceuticals (NYSE: KG) to resubmit its application for its joint, abuse-resistant formulation of OxyContin, called Remoxy. Using a...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to 5 Top Stocks at Half Price
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
